Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

BMJ Open Diabetes Research & Care, 2022
Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes

Espes D., Magnusson L., Caballero-Corbalan J. et al.

Olink Target 96Metabolic DiseasesObstetricsPathophysiologyPlasma

Obesity, 2022
The inflammatory proteome, obesity, and medical weight loss and regain in humans

Perry A., Tanriverdi K., Risitano A. et al.

Olink Target 96Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Clinical and Translational Science, 2022
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study

Mi J., Wu X., Bai X. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Journal of Clinical Immunology, 2022
Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients

Ebihara T., Matsubara T., Togami Y. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

PLOS ONE, 2022
Protein biomarker profiles in serum and CSF in 158 patients with PTLDS or persistent symptoms after presumed tick-bite exposure compared to those in patients with confirmed acute neuroborreliosis

Nilsson K., Skoog E., Edvinsson M. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerumCSF

Obesity, 2022
Proteomics, dietary intake, and changes in cardiometabolic health within a behavioral weight‐loss intervention: A pilot study

Hill E., Siebert J., Yazza D. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors

Natoli M., Hatje K., Gulati P. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyCell Culture Lysate

Cell Systems, 2022
Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection

Sauerwald N., Zhang Z., Ramos I. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Scientific Reports, 2022
Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease

Kremers B., Posma J., Heitmeier S. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Davis E., Martin-Liberal J., Kristeleit R. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Allergy, 2022
Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation: A 24‐year follow‐up

Tedner S., Klevebro S., Bergström A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Biomedicines, 2022
Quantitative Proteomics Indicate Radical Removal of Non-Small Cell Lung Cancer and Predict Outcome

Bodén E., Andreasson J., Hirdman G. et al.

Olink Target 96OncologyPatient StratificationPlasma

Journal of Proteome Research, 2022
Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia

Wang X., Yip K., He A. et al.

Olink Target 96ObstetricsPatient StratificationPlasma

Mucosal Immunology, 2022
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism

Cavounidis A., Pandey S., Capitani M. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Immunity, Inflammation and Disease, 2022
Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients

de Graaf D., Teufel L., de Nooijer A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

The Journal of Clinical Endocrinology & Metabolism, 2022
The Acute Cytokine Response to 30-Minute Exercise Bouts Before and After 8-Week Endurance Training in Individuals With Obesity

Goj T., Hoene M., Fritsche L. et al.

Olink Target 96Metabolic DiseasesPathophysiologySerum

Nature Genetics, 2022
Multiomics study of nonalcoholic fatty liver disease

Sveinbjornsson G., Ulfarsson M., Thorolfsdottir R. et al.

Olink Explore 3072/384HepatologyPathophysiologyPatient StratificationPlasma

Movement Disorders, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease

Bartl M., Dakna M., Schade S. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

The Journal of Clinical Endocrinology & Metabolism, 2022
Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes

Straat M., Martinez-Tellez B., van Eyk H. et al.

Olink Target 96Metabolic DiseasesPatient StratificationPlasma

Nature Communications, 2022
Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

Rabold K., Zoodsma M., Grondman I. et al.

Olink Target 96OncologyPathophysiologyPlasma

1945 publications